title: Caveat against the use of feiba in combination with recombinant factor viia.
authors.forename: Christian
authors.initials: C
authors.lastname: von Heymann
authors.forename: Sabine
authors.initials: S
authors.lastname: Ziemer
authors.forename: Wolfgang J
authors.initials: WJ
authors.lastname: Kox
authors.forename: Claudia
authors.initials: C
authors.lastname: Spies
mesh_terms: D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000009:adverse effects*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015199:Extracorporeal Membrane Oxygenation; D005167:Factor VII / Q000008:administration & dosage / Q000009:adverse effects*; D017809:Fatal Outcome; D006470:Hemorrhage / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D012720:Severity of Illness Index; D013927:Thrombosis / Q000139:chemically induced*
chemical_list: D001779:Blood Coagulation Factors; D005167:Factor VII; C065655:anti-inhibitor coagulant complex